Macro shot of dozator tip and plastic plate for immunosorbent assay, molecular  diagnostics


tubes with colored liquid in a rackDiagnostic tools developed by Viravaxx are based on microarrayed proteins and peptides, which are derived from structural proteins of relevant viruses.

Focusing the potential of the technology on HRV, HIV and RSV, the devices will support identification of the strains, clades and serotypes which are most relevant for the course of the respective diseases. They allow the exhaustive analysis of the immune response of an infected individual to a virus encounter. Eventually this analysis will guide the development of vaccines for these clinically important strains.

These arrays are developed in close collaboration with Prof. Rudolf Valenta’s research group at the Medical University of Vienna (MUW) and can be adapted to any existing or emerging arraying technology platform.

diagnostics chart